Correlation Between Axsome Therapeutics and Cognition Therapeutics
Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and Cognition Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and Cognition Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Therapeutics and Cognition Therapeutics, you can compare the effects of market volatilities on Axsome Therapeutics and Cognition Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of Cognition Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and Cognition Therapeutics.
Diversification Opportunities for Axsome Therapeutics and Cognition Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Axsome and Cognition is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and Cognition Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cognition Therapeutics and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with Cognition Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cognition Therapeutics has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and Cognition Therapeutics go up and down completely randomly.
Pair Corralation between Axsome Therapeutics and Cognition Therapeutics
Given the investment horizon of 90 days Axsome Therapeutics is expected to under-perform the Cognition Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Axsome Therapeutics is 1.19 times less risky than Cognition Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Cognition Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 194.00 in Cognition Therapeutics on January 31, 2024 and sell it today you would lose (1.00) from holding Cognition Therapeutics or give up 0.52% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Axsome Therapeutics vs. Cognition Therapeutics
Performance |
Timeline |
Axsome Therapeutics |
Cognition Therapeutics |
Axsome Therapeutics and Cognition Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Axsome Therapeutics and Cognition Therapeutics
The main advantage of trading using opposite Axsome Therapeutics and Cognition Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, Cognition Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cognition Therapeutics will offset losses from the drop in Cognition Therapeutics' long position.Axsome Therapeutics vs. Amgen Inc | Axsome Therapeutics vs. Fidelity Freedom Blend | Axsome Therapeutics vs. Income Fund Of | Axsome Therapeutics vs. HP Inc |
Cognition Therapeutics vs. Reviva Pharmaceuticals Holdings | Cognition Therapeutics vs. Eyenovia | Cognition Therapeutics vs. Transcode Therapeutics | Cognition Therapeutics vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stocks Directory Find actively traded stocks across global markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |